Jump to section
To provide exceptional care for animals and those who care for them through personalized products and exceptional experiences.
-9% employee growth in 12 months
The pharmacy experience has dramatically changed in recent years with the advent of at-home delivery. However the veterinary side of the industry is not keeping up with these developments.
Mixlab is modernizing the pharmacy experience for vets and our pets. Veterinarians that use Mixlab’s digital service can streamline their daily medication workflow, giving them more time to spend on actual patients.
The startup is now going further than just delivery and administrative streamlining. It's making its own medications on demand that are flavored and dosed. It's in this vein that the company wants to continue to expand, providing a pharmaceutical service that humans would be jealous of.
It's an impressive ambition, but ultimately will rely on the trust of its veterinarian customers. So far, in this respect, Mixlab has delivered, with its footprint expanding to all 50 states in 2025, alongside a string of acquisitions. Off the back of a 75% increase in year-on-year growth, 2026 saw Mixlab release its Maisy, an AI partner for veterinarians and their customers. It's clear then that Mixlab's bite matches its bark.

Kirsty
Company Specialist at Welcome to the Jungle
Aug 2023
$10m
SERIES A
Aug 2021
$20m
SERIES A
This company has top investors
Frederic Dijols
(Founder & CEO)Previously an Associate at J.P. Morgan. Earned an MBA from Harvard Business School. Prior to that, worked as a Senior R&D Engineer at Johnson & Johnson.